a slight significancep =0.064
In addition, a slight significance ( p =0.064) was found for the triple interaction duration x psychiatric comorbidities x time.
In addition, a slight significance ( p =0.064) was found for the triple interaction duration x psychiatric comorbidities x time.
In the erenumab group, CGRP levels showed no significant change, though responders exhibited a decreasing trend from T0 to T2 compared to non-responders.
Conclusion Short-lasting oxytocin inhibition through the OT-receptor antagonist atosiban did not significantly increase the incidence of migraine attacks in women with episodic migraine, although a numerical trend was observed.
Deprivation had an increasing trend with the percentage of the migraine cohort prescribed medication: any acute medication (56.5%-70.2%) (Fig. 2 A); any preventive medication (31.8%-42.7%) (Fig. 3 A).